Comparative studies of glycosaminoglycan involvement in Chlamydia pneumoniae and C. trachomatis Invasion of host cells

Journal of Infectious Diseases

Volumn 187, Issue 8, 2003, Pages 1291-1300

  Beswick, Ellen J ^a,b   Travelstead, Anna ^a   Cooper, Morris D ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSAMINOGLYCAN;

ARTICLE; BRONCHUS MUCOSA; CELL INVASION; CELL SURFACE; CHLAMYDIA TRACHOMATIS; CHLAMYDOPHILA PNEUMONIAE; CHO CELL; ENDOTHELIUM CELL; EPITHELIUM CELL; HOST CELL; HUMAN; HUMAN CELL; INFECTION RATE; PRIORITY JOURNAL; SEROTYPE; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

ANIMALS; CELL ADHESION; CHLAMYDIA TRACHOMATIS; CHLAMYDOPHILA PNEUMONIAE; CHO CELLS; CRICETINAE; GLYCOSAMINOGLYCANS; HUMANS;

EID: 0037446910     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/374056     Document Type: Article

References (37)

1. Grayston JT, Campbell LA, Kuo CC, et al. A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR. J Infect Dis 1990; 161:618-25.
2. Grimwood J, Olinger L, Stephens RS. Expression of Chlamydia pneumoniae polymorphic membrane protein family genes. Infect Immun 2001; 69:2383-9.
3. Grayston JT. Infections caused by Chlamydia pneumoniae strain TWAR. Clin Infect Dis 1992; 15:757-61.
4. Moling O, Pegoretti S, Rielli M, et al. Chlamydia pneumoniae-reactive arthritis and persistent infection. Br J Rheumatol 1996; 35:1189-90.
5. Gran JT, Hjetland R, Andreassen AH. Pneumonia, myocarditis and reactive arthritis due to Chlamydia pneumoniae. Scand J Rheumatol 1993; 22:43-4.
6. Rutherford JD. Chlamydia pneumoniae and atherosclerosis. Curr Atheroscler Rep 2000; 2:218-25.
7. Saikku P. Chlamydia pneumoniae in atherosclerosis. J Intern Med 2000; 247:391-6.
8. Su H, Raymond L, Rockey DD, et al. A recombinant Chlamydia trachomatis major outer membrane protein binds to heparan sulfate receptors on epithelial cells. Proc Natl Acad Sci USA 1996; 93:11143-8.
9. Taraktchoglou M, Pacey AA, Turnbull JE, Eley A. Infectivity of Chlamydia trachomatis serovar LGV but not E is dependent on host cell heparan sulfate. Infect Immun 2001; 69:968-76.
10. Wadstrom T, Ljungh A. Giycosaminoglycan-binding microbial proteins in tissue adhesion and invasion: key events in microbial pathogenicity. J Med Microbiol 1999; 48:223-33.
11. Hook M, Kjellen L, Johansson S. Cell-surface glycosaminoglycans. Annu Rev Biochem 1984; 53:847-69.
12. Su H, Watkins NG, Zhang YX, Caldwell HD. Chlamydia trachomatis-host ceil interactions: role of the chlamydial major outer membrane protein as an adhesin. Infect Immun 1990; 58:1017-25.
13. Zhang JP, Stephens RS. Mechanism of C. trachomatis attachment to eukaryotic host cells. Cell 1992; 69:861-9.
14. Davis CH, Wyrick PB. Differences in the association of Chlamydia trachomatis serovar E and serovar L2 with epithelial cells in vitro may reflect biological differences in vivo. Infect Immun 1997; 65:2914-24.
15. Gaydos CA, Summersgill JT, Sahney NN, Ramirez JA, Quinn TC. Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells. Infect Immun 1996; 64:1614-20.
16. Summersgill JT, Molestina RE, Miller RD, Ramirez JA. Interactions of Chlamydia pneumoniae with human endothelial cells. J Infect Dis 2000; 181(Suppl 3):S479-82.
17. Chen JC, Stephens RS. Trachoma and LGV biovars of Chlamydia trachomatis share the same glycosaminoglycan-dependent mechanism for infection of eukaryotic cells. Mol Microbiol 1994; 11:501-7.
18. Stephens RS, Fawaz FS, Kennedy KA, et al. Eukaryotic cell uptake of heparin-coated microspheres: a model of host cell invasion by Chlamydia trachomatis. Infect Immun 2000; 68:1080-5.
19. Newhall WJ, Batteiger B, Jones RB. Analysis of the human serological response to proteins of Chlamydia trachomatis. infect Immun 1982; 38:1181-9.
20. Herold BC, Bourne N, Marcellino D, et al. Poly(sodium 4-styrene sulfonate): an effective candidate topical antimicrobial for the prevention of sexually transmitted diseases. J Infect Dis 2000; 181:770-3.
21. Lavabre-Bertrand T, Poncelet P. Antigen density in B-cell chronic lymphocytic leukemia. Am J Clin Pathol 1995; 103:375.
22. Poncelet P, George F, Papa S, Lanza F. Quantitation of hemopoietic cell antigens in flow cytometry. Eur J Histochem 1996; 40 (Suppl 1):15-32.
23. Swanson KV, Jarvis GA, Brooks GF, Barham BJ, Cooper MD, Griffiss JM. CEACAM is not necessary for Neisseria gonorrhoeae to adhere to and invade female genital epithelial cells. Cell Microbiol 2001; 3:681-91.
24. Chen JC, Zhang JP, Stephens RS. Structural requirements of heparin binding to Chlamydia trachomatis. J Biol Chem 1996; 271:11134-40.
25. Dessus-Babus S, Belloc F, Bebear CM, et al. Antibiotic susceptibility testing for Chlamydia trachomatis using flow cytometry. Cytometry 1998; 31:37-44.
26. Levitt D, Zable B, Bard J. Binding, ingestion, and growth of Chlamydia trachomatis (L2 serovar) analyzed by flow cytometry. Cytometry 1986; 7:378-83.
27. Waldman FM, Hadley WK, Fulwyler MJ, Schachter J. Flow cytometric analysis of Chlamydia trachomatis interaction with L cells. Cytometry 1987; 8:55-9.
28. Wuppermann FN, Hegemann JH, Jantos CA. Heparan sulfate-like glycosaminoglycan is a cellular receptor for Chlamydia pneumoniae. J Infect Dis 2001; 184:181-7.
29. Soderlund G, Kihlstrom E. Physicochemical surface properties of elementary bodies from different serotypes of Chlamydia trachomatis and their interaction with mouse fibroblasts. Infect Immun 1982; 36:893-9.
30. Lidholt K, Weinke JL, Kiser CS, et al. A single mutation affects both N-acetylglucosaminyltransferase and glucuronosyltransferase activities in a Chinese hamster ovary cell mutant defective in heparan sulfate biosynthesis. Proc Natl Acad Sci USA 1992; 89:2267-71.
31. Esko JD, Weinke JL, Taylor WH, et al. Inhibition of chondroitin and heparan sulfate biosynthesis in Chinese hamster ovary cell mutants defective in galactosyltransferase I. J Biol Chem 1987; 262:12189-95.
32. Rasmussen-Lathrop SJ, Koshiyama K, Phillips N, Stephens RS. Chlamydia-dependent biosynthesis of a heparan sulphate-like compound in eukaryotic cells. Cell Microblol 2000; 2:137-44.
33. Kalman S, Mitchell W, Marathe R, et al. Comparative genomes of Chlamydia pneumoniae and C. trachomatis. Nat Genet 1999; 21:385-9.
34. Stephens RS, Kalman S, Lammel C, et al. Genome sequence of an obligate intracellular pathogen of humans: Chlamydia trachomatis. Science 1998; 282:754-9.
35. Zaretzky FR, Pearce-Pratt R, Phillips DM. Sulfated polyanions block Chlamydia trachomatis infection of cervix-derived human epithelia. Infect Immun 1995; 63:3520-6.
36. Carabeo RA, Hackstadt T. Isolation and characterization of a mutant Chinese hamster ovary cell line that is resistant to Chlamydia trachomatis infection at a novel step in the attachment process. Infect Immun 2001; 69:5899-904.
37. Stephens RS, Koshiyama K, Lewis E, Kubo A. Heparin-binding outer membrane protein of chlamydiae. Mol Microbiol 2001; 40:691-9.